Limits...
New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma.

Agulnik M - Cancer (2011)

Bottom Line: The mammalian target of rapamycin (mTOR), a serine-threonine protein kinase in the phosphatidylinositol 3-kinase/serine/threonine protein kinase Akt signaling pathway, has an important role in the regulation of protein synthesis, cell proliferation, angiogenesis, and metabolism.Alterations of the mTOR signaling pathway are common in malignancies, including several types of sarcoma.Rapamycin and its analogs (rapalogs) are effective anticancer agents in a broad range of preclinical models.

View Article: PubMed Central - PubMed

Affiliation: Division of Medical Hematology/Oncology, Northwestern University, Chicago, Illinois, USA. m-agulnik@northwestern.edu

Show MeSH

Related in: MedlinePlus

The mammalian target of rapamycin (mTOR) signaling cascade and its function are illustrated. GF indicates growth factor; IGF, insulin-like growth factor; RTK, receptor tyrosine kinase; IRS-1, insulin receptor substrate 1; PI3K, phosphatidylinositol 3 kinase; PIP, phosphatidylinositol-4,5-bisphosphate; PKB, phosphate kinase B; LKB1, serine threonine kinase 11; PTEN, phosphatase and tensin homolog (deleted on chromosome 10); PDK1, 3-phosphoinositide-dependent protein kinase 1; T308, threonine 308; S473, serine 472; AMPK, adenine monophosphate-activated kinase; TSC, tuberous sclerosis complex; Rheb, Ras homolog enriched in brain; FKBP12, 12-kDa FK506-binding protein; mLST8, G protein subunit like (mTOR complex subunit LST8); S6K1, protein S6 kinase 1; 4E-BP1, eukaryotic initiation factor 4E binding protein-1; rpS6, ribosomal protein S6; elF-4E, eukaryotic initiation factor 4E; HIF-1α, hypoxia inducible factor 1α; VEGF, vascular endothelial growth factor.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC3412949&req=5

fig01: The mammalian target of rapamycin (mTOR) signaling cascade and its function are illustrated. GF indicates growth factor; IGF, insulin-like growth factor; RTK, receptor tyrosine kinase; IRS-1, insulin receptor substrate 1; PI3K, phosphatidylinositol 3 kinase; PIP, phosphatidylinositol-4,5-bisphosphate; PKB, phosphate kinase B; LKB1, serine threonine kinase 11; PTEN, phosphatase and tensin homolog (deleted on chromosome 10); PDK1, 3-phosphoinositide-dependent protein kinase 1; T308, threonine 308; S473, serine 472; AMPK, adenine monophosphate-activated kinase; TSC, tuberous sclerosis complex; Rheb, Ras homolog enriched in brain; FKBP12, 12-kDa FK506-binding protein; mLST8, G protein subunit like (mTOR complex subunit LST8); S6K1, protein S6 kinase 1; 4E-BP1, eukaryotic initiation factor 4E binding protein-1; rpS6, ribosomal protein S6; elF-4E, eukaryotic initiation factor 4E; HIF-1α, hypoxia inducible factor 1α; VEGF, vascular endothelial growth factor.

Mentions: Mammalian target of rapamycin is a member of the PI3K-kinase related kinase superfamily.11, 12 Human mTOR exists in 2 different multiprotein complexes: mTOR complex 1 (mTORC1), consisting of mTOR, mTOR complex subunit LST8 (mLST8), and regulatory-associated protein of mTOR (raptor); and mTOR complex 2 (mTORC2), composed of mTOR, mLST8, rapamycin-insensitive companion of mTOR (rictor), and mammalian stress-activated protein kinase-interacting protein 1 (mSin1).12 Of the 2 complexes, mTORC1 has been studied more extensively and reportedly regulates most mTOR effects on protein synthesis and gene expression associated with cell growth, metabolism, cell proliferation, angiogenesis, and cell survival. The role of mTORC2 is less understood, but reports suggest that mTORC2 phosphorylates Akt in the PI3K/Akt pathway and regulates the organization of the cytoskeleton (Fig. .1).6-8, 13, 14 The activity of mTOR is regulated by growth factors and their receptors, which transmit signals through the PI3K/Akt and Ras pathways.9 Members of the EGFR family (eg, EGFR, human epidermal growth factor 2), IGF, and VEGF receptors stimulate mTOR activity through the small guanosine triphosphatase (GTPase) Ras homolog enriched in brain.9 Signals generated by these receptors are regulated by PTEN, which inhibits PI3K signaling; neurofibromatosis type-1 (NF1), a tumor suppressor that reduces Ras activity; and tuberous sclerosis complex (TSC1) and TSC2, which form a complex to block the activation of mTOR.11 The activity of mTOR also is regulated by cellular stress—when intracellular adenosine triphosphate (ATP) levels are depleted, the adenosine monophosphate-activated protein kinase is activated through the tumor suppressor LKB1 (serine threonine kinase 11). Adenosine monophosphate-activated protein kinase subsequently activates another tumor suppressor, TSC1/TSC2, thereby leading to mTOR inactivation.10, 14


New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma.

Agulnik M - Cancer (2011)

The mammalian target of rapamycin (mTOR) signaling cascade and its function are illustrated. GF indicates growth factor; IGF, insulin-like growth factor; RTK, receptor tyrosine kinase; IRS-1, insulin receptor substrate 1; PI3K, phosphatidylinositol 3 kinase; PIP, phosphatidylinositol-4,5-bisphosphate; PKB, phosphate kinase B; LKB1, serine threonine kinase 11; PTEN, phosphatase and tensin homolog (deleted on chromosome 10); PDK1, 3-phosphoinositide-dependent protein kinase 1; T308, threonine 308; S473, serine 472; AMPK, adenine monophosphate-activated kinase; TSC, tuberous sclerosis complex; Rheb, Ras homolog enriched in brain; FKBP12, 12-kDa FK506-binding protein; mLST8, G protein subunit like (mTOR complex subunit LST8); S6K1, protein S6 kinase 1; 4E-BP1, eukaryotic initiation factor 4E binding protein-1; rpS6, ribosomal protein S6; elF-4E, eukaryotic initiation factor 4E; HIF-1α, hypoxia inducible factor 1α; VEGF, vascular endothelial growth factor.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC3412949&req=5

fig01: The mammalian target of rapamycin (mTOR) signaling cascade and its function are illustrated. GF indicates growth factor; IGF, insulin-like growth factor; RTK, receptor tyrosine kinase; IRS-1, insulin receptor substrate 1; PI3K, phosphatidylinositol 3 kinase; PIP, phosphatidylinositol-4,5-bisphosphate; PKB, phosphate kinase B; LKB1, serine threonine kinase 11; PTEN, phosphatase and tensin homolog (deleted on chromosome 10); PDK1, 3-phosphoinositide-dependent protein kinase 1; T308, threonine 308; S473, serine 472; AMPK, adenine monophosphate-activated kinase; TSC, tuberous sclerosis complex; Rheb, Ras homolog enriched in brain; FKBP12, 12-kDa FK506-binding protein; mLST8, G protein subunit like (mTOR complex subunit LST8); S6K1, protein S6 kinase 1; 4E-BP1, eukaryotic initiation factor 4E binding protein-1; rpS6, ribosomal protein S6; elF-4E, eukaryotic initiation factor 4E; HIF-1α, hypoxia inducible factor 1α; VEGF, vascular endothelial growth factor.
Mentions: Mammalian target of rapamycin is a member of the PI3K-kinase related kinase superfamily.11, 12 Human mTOR exists in 2 different multiprotein complexes: mTOR complex 1 (mTORC1), consisting of mTOR, mTOR complex subunit LST8 (mLST8), and regulatory-associated protein of mTOR (raptor); and mTOR complex 2 (mTORC2), composed of mTOR, mLST8, rapamycin-insensitive companion of mTOR (rictor), and mammalian stress-activated protein kinase-interacting protein 1 (mSin1).12 Of the 2 complexes, mTORC1 has been studied more extensively and reportedly regulates most mTOR effects on protein synthesis and gene expression associated with cell growth, metabolism, cell proliferation, angiogenesis, and cell survival. The role of mTORC2 is less understood, but reports suggest that mTORC2 phosphorylates Akt in the PI3K/Akt pathway and regulates the organization of the cytoskeleton (Fig. .1).6-8, 13, 14 The activity of mTOR is regulated by growth factors and their receptors, which transmit signals through the PI3K/Akt and Ras pathways.9 Members of the EGFR family (eg, EGFR, human epidermal growth factor 2), IGF, and VEGF receptors stimulate mTOR activity through the small guanosine triphosphatase (GTPase) Ras homolog enriched in brain.9 Signals generated by these receptors are regulated by PTEN, which inhibits PI3K signaling; neurofibromatosis type-1 (NF1), a tumor suppressor that reduces Ras activity; and tuberous sclerosis complex (TSC1) and TSC2, which form a complex to block the activation of mTOR.11 The activity of mTOR also is regulated by cellular stress—when intracellular adenosine triphosphate (ATP) levels are depleted, the adenosine monophosphate-activated protein kinase is activated through the tumor suppressor LKB1 (serine threonine kinase 11). Adenosine monophosphate-activated protein kinase subsequently activates another tumor suppressor, TSC1/TSC2, thereby leading to mTOR inactivation.10, 14

Bottom Line: The mammalian target of rapamycin (mTOR), a serine-threonine protein kinase in the phosphatidylinositol 3-kinase/serine/threonine protein kinase Akt signaling pathway, has an important role in the regulation of protein synthesis, cell proliferation, angiogenesis, and metabolism.Alterations of the mTOR signaling pathway are common in malignancies, including several types of sarcoma.Rapamycin and its analogs (rapalogs) are effective anticancer agents in a broad range of preclinical models.

View Article: PubMed Central - PubMed

Affiliation: Division of Medical Hematology/Oncology, Northwestern University, Chicago, Illinois, USA. m-agulnik@northwestern.edu

Show MeSH
Related in: MedlinePlus